$ 1,250.0
Quantity: 1 G
In stock
Description
Product name: Semaglutide
Catalog#: 1225010-2
Synonyms: NN 9535;NN9535;NNC 0113-0217;UNII-53AXN4NNHX;
CAS NO.: 910463-68-2
Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Modifications:
M.W: 4113.58
M.F.: C187H291N45O59
Purity: 95%
Counter ion: Acetate
Format: Lyophilized powder
Description: Semaglutide is a once-daily -like peptide-1 analog that differs to others by the presence of an acyl group with a steric diacid at Lys26 and a large synthetic spacer and modified by the presence of a α-aminobutyric acid in position 8 which gives stability against the dipeptidylpeptidase-4.1 The stability of semaglutide by the acylation permits a high-affinity albumin binding and gives it a long plasma half-life which allows the once-daily dosage. It was developed by the Danish pharmaceutical company Novo Nordisk and FDA approved on December 5, 2017.6
Uniprot ID:
Usage: For Scientific Research Use Only, Not for Human Use.
